45
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Alzheimer's disease biomarkers are important for early diagnosis in routine clinical practice and research. Three core CSF biomarkers for the diagnosis of Alzheimer's disease (Aβ42, T-tau, and P-tau) have been assessed in numerous studies, and several other Alzheimer's disease markers are emerging in the literature. However, there have been no comprehensive meta-analyses of their diagnostic performance. We systematically reviewed the literature for 15 biomarkers in both CSF and blood to assess which of these were most altered in Alzheimer's disease.

          Related collections

          Author and article information

          Journal
          Lancet Neurol
          The Lancet. Neurology
          1474-4465
          1474-4422
          Jun 2016
          : 15
          : 7
          Affiliations
          [1 ] Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. Electronic address: bob.olsson@neuro.gu.se.
          [2 ] Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
          [3 ] Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Biomedical Sciences, University of Antwerp, Belgium.
          [4 ] Department of Radiation Physics, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
          [5 ] Alzforum, Cambridge, MA, USA.
          [6 ] Unit for Health Metrics, Department of Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
          [7 ] Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
          Article
          S1474-4422(16)00070-3
          10.1016/S1474-4422(16)00070-3
          27068280
          3bd15601-7d2c-405e-baaa-6581a6a37c37
          Copyright © 2016 Elsevier Ltd. All rights reserved.
          History

          Comments

          Comment on this article